UBI Ubisoft Entertainment SA

Disclosure of trading in own shares - Pre-paid forward agreement on own shares

Disclosure of trading in own shares - Pre-paid forward agreement on own shares

DISCLOSURE OF TRADING IN OWN SHARES

PRE-PAID FORWARD AGREEMENT ON OWN SHARES

(partial early settlement)

Paris, September 18, 2023 Ubisoft Entertainment SA (Euronext Paris: UBI – ISIN code FR0000054470) has decided on September 7, 2023, by virtue of the opportunity offered under the terms of the pre-paid forward agreement entered into on March 20, 2018 with Crédit Agricole Corporate and Investment Bank (the "Agreement")1, to settle by anticipation the Agreement for an amount of 489,547 treasury shares (the "Shares") out of the remaining balance under the Agreement of 2,245,454 Shares2.

The delivery of the Shares (in pure registered form) on September 12, 2023 to Uptevia, is part of the share buyback program authorized by the General Meeting of Ubisoft Entertainment SA on July 5, 2022.

These Shares are intended to be used to cover employee shareholding plans.

Issuer corporate

name
Issuer identification code Settlement Purchase/Sale Options/Futures
Ubisoft Entertainment sa 969500I7C8V1LBIMSM05 September 7, 2023 Purchase Partial early settlement of the pre-paid forward agreement by delivery of the shares



Number of shares Financial instrument identification code Delivery Market Purpose of the purchases
489,547 FR0000054470 September 12, 2023 Over the counter Employee share ownership plans coverage

This operation has no impact in terms of dilution or on Ubisoft Entertainment SA’s net cash position.


1         to be settled at maturity (March 22, 2024) or by anticipation, in whole or in part, by Ubisoft Entertainment SA

2 Cf. "" - March 20, 2018 / Cf. "" - March 29, 2018 / Cf. "" - September 15, 2020 / Cf. "" - September 15, 2022 / Cf. "" - June 21, 2023

 

Attachment



EN
18/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ubisoft Entertainment SA

 PRESS RELEASE

Informations sur les droits de vote et les actions au 30 septembre 202...

Informations sur les droits de vote et les actions au 30 septembre 2025 Le 8 octobre 2025 Information relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Information mensuelle au 30 septembre 2025(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Date Nombre total ...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PEGA PEGASYSTEMS INC.
PANW PALO ALTO NETWORKS INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
IMAX IMAX CORPORATION
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
ZG ZILLOW GROUP INC. CLASS A
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
STOK STOKE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
APGE APOGEE THERAPEUTICS INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
LAC. LITHIUM AMERICAS CORP NEW
ORKA ORUKA THERAPEUTICS INC
ZBIO ZENAS BIOPHARMA INC.
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
 PRESS RELEASE

Informations sur les droits de vote et les actions au 31 août 2025

Informations sur les droits de vote et les actions au 31 août 2025    Le 11 septembre 2025 Information relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Information mensuelle au 31 août 2025(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Date Nombre total d’actions composa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch